Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06229093 · ClinicalTrials.gov registry record · NA

Multimodal Musical Stimulation for Healthy Neurocognitive Aging

A NA study of Aging, sponsored by Northeastern University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06229093 is a NA study of Aging that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 100 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06229093, a NA study of Aging, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a Stage I randomized, sham-controlled trial on the effects of multimodal musical stimulation on working memory in aging. Neurologically healthy older and younger adults will be tested on working memory and electroencephalography in the first randomized controlled trial of music as a form of brain stimulation, with multimodal musical stimulation and control stimulation conditions. Results will test the causal role of oscillatory mechanisms of the brain on cognition, and will lay the groundwork to the first musical, neurophysiologically targeted, brain-stimulation device for reversing cognitive decline in aging.

Conditions Studied

Interventions

  • DEVICE Gamma
  • DEVICE Synchrony

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-12-11
Est. Completion 2027-12-31
Phase NA

Sponsor

Northeastern University

39 total trials

What the Registry Record Tells You About NCT06229093

The ClinicalTrials.gov registry entry for NCT06229093 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The listed sponsor is Northeastern University, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Gamma is the first listed.

NCT06229093 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06229093 about?

NCT06229093 is a clinical study titled "Multimodal Musical Stimulation for Healthy Neurocognitive Aging". This is a Stage I randomized, sham-controlled trial on the effects of multimodal musical stimulation on working memory in aging. Neurologically healthy older and younger adults will be tested on working memory and electroencephalography in the first randomized controlled trial of music as a form of ...

What is the current status of trial NCT06229093?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-12-11. Estimated completion is 2027-12-31.

What conditions does trial NCT06229093 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06229093?

The interventions under investigation include: Gamma (DEVICE), Synchrony (DEVICE).

Who is sponsoring clinical trial NCT06229093?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06229093 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.